The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Apretude
Device/Product Name
Apretude
Active ingredients
Cabotegravir (as sodium (tablet), and as free acid (suspension for injection))
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04853-1-2
Submission Type
Extension of indications
Decision
Approved